Integra LifeSciences Holdings (IART) 2010年年度报告「NASDAQ」.pdf

1、LIMITING UNCERTAINTY IS HOW WE MAKE A DIFFERENCE.Integra 2010 Annual ReportTotal RevenuesOperating Cash FlowDiluted Earnings Per ShareSelected Financial Data:Company at a GlanceFoundedin1989andheadquarteredinPlainsboro,NJGrowingshareinspineandextremityreconstructionwithintheorthopedicmarketMarketlea

2、dershipinneurosurgeryandmedicalinstrumentsEmploysapproximately3,000worldwideSellsthroughdirectrepsintheU.S.,Canada,majorEuropeanmarketsandAustralia,andthroughdistributorsintheseandover100countries2010 Revenues by Geographic AreaRegion2010RevenuesUnitedStates$561.2Europe$89.4AsiaPacific$40.6OtherFore

3、ign$40.92010RevenuesbyProductCategoryProduct Category%of Total Revenues Key Product Areas YTD 2010 RevenuesOrthopedics40%MISspinesystem,traditionalspinefusion,$290Millionextremityreconstruction,orthobiologics,skin&woundNeurosurgery37%Duralgraft,cranialstabilization,$275MillionCSFmanagement,ultrasoni

4、caspiration,neuromonitoringInstruments23%Generalandspecialtyhand-heldsurgical$167Millioninstrumentsinthehospitalandoffice-basedsettings,surgicalheadlightsTo our Stockholders:In 2010,each of our diverse product categories significantly improved notwithstanding the stillchallenging economy,reflecting

5、ourstrongcustomer relationships andourcommitment tothe hospitalsandsurgeonswe serve.We deepened and extended the maturity of ourcapital structure through a majorrefinancing,which will permit us to make disciplined acquisitions and substantial investments in newand more efficient processes and produc

6、tion capacity.We invested in infrastructure and people toprepare our business for further growth when the hospital economy strengthens.We have entered moremarkets around the world,introduced new products that fulfill important needs,and increased our topand bottom lines.In2010,welaunched ournewcorpo